News bioMérieux

Stocks

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-07-16 am EDT			After hours 12:57:33 pm
72.70 ^EUR	+1.18%		72.62	-0.10%

10:38am	MedTech facing a three-front squeeze
Jul. 14	Biomérieux Showcases Latest Diagnostic Solutions and Innovations At ADLM 2026	CI

All News

Mentions Relevance

Jul. 14	Biomérieux Showcases Latest Diagnostic Solutions and Innovations At ADLM 2026	CI
Jul. 10	Sadif Investment Analytics Upgrades bioMérieux to Hold Rating	MT
Jul. 08	BioMérieux Launches Gene-Up Probiotic Species Id Pcr Solution For Species-Level Identification In Dietary Supplements Manufacturing	CI
Jun. 30	BioMérieux in the red despite positive news
Jun. 30	Biomérieux Submits 510(K) to U.S. Fda for Latest Versions of Biofire Filmarray Gastrointestinal Panels to Enhance Detection of Gastrointestinal Pathogens	CI
Jun. 26	BioMérieux Files Dual 510(K) / CLIA Waiver Application To FDA For BIOFIRE SPOTFIRE Vaginitis Panel	CI
Jun. 24	Barclays Cuts BioMérieux's PT, Affirms Equalweight Rating	MT
Jun. 23	Morgan Stanley Downgrades bioMérieux to Underweight, Cuts PT	MT
Jun. 22	RBC Capital Cuts bioMérieux PT, Affirms Sector Perform Rating	MT
Jun. 18	BioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry	PR
Jun. 18	BioMérieux Introduces Salmonella Testing Kit on GENE-UP TYPER to Support Root Cause Analysis in the Food Industry	CI
Jun. 18	BioMérieux Launches New Salmonella Diagnostic Test
Jun. 01	BioMérieux in the red following UBS downgrade
Jun. 01	UBS Downgrades bioMérieux to Neutral, Cuts PT	MT
Jun. 01	UBS downgrades bioMérieux to neutral, shares retreat
Jun. 01	French Analyst Ratings: UBS downgrades Biomerieux, Soitec remains in favor
May. 29	Biomérieux Invests EUR 250 Million to Build New Manufacturing Facility in France	CI
May. 29	BioMérieux to build new production facility in Isère
May. 29	BioMérieux to Spend EUR250 Million on New French Manufacturing Facility	MT
May. 27	Minaris Advanced Therapies, LLC Expands Rapid Mycoplasma Detection Services With bioMérieux's BIOFIRE Platform To Reduce Turnaround Time For Release And In-Process Testing	CI
May. 19	Test shortages slow fight against Ebola in Congo, WHO official says	RE
May. 06	L'Institut Merieux: bought an extra 1% in Biomérieux, bringing its total stake in company to around 60%	RE
May. 04	BioMerieux : AG 2026 - 2025 Parent company financial statements	PU
May. 04	BioMerieux : AG 2026 - 2025 List of directors	PU
May. 04	BioMerieux : AG 2026 - 2025 Consolidated financial statements	PU